Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
J04AK01
|
| gptkbp:CASNumber |
98-96-4
|
| gptkbp:hasInChIKey |
JZEBZQFQFQNLJU-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
gptkb:C5H5N3O
|
| gptkbp:hasSMILES |
C1=NC=CN=C1C(=O)N
|
| https://www.w3.org/2000/01/rdf-schema#label |
pyrazine-2-carboxamide
|
| gptkbp:is_listed_on_WHO_Model_List_of_Essential_Medicines |
true
|
| gptkbp:is_metabolized_to |
pyrazinoic acid
|
| gptkbp:IUPACName |
gptkb:pyrazine-2-carboxamide
|
| gptkbp:meltingPoint |
210-212°C
|
| gptkbp:molecularWeight |
123.12 g/mol
|
| gptkbp:partOf |
tuberculosis treatment regimen
|
| gptkbp:PubChem_CID |
7517
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:pyrazinamide
2-pyrazinecarboxamide |
| gptkbp:usedFor |
antineoplastic agent
|
| gptkbp:was_discovered_in |
1952
|
| gptkbp:bfsParent |
gptkb:pyrazinamide
|
| gptkbp:bfsLayer |
6
|